Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/11/882
Active ingredient: Fresolimumab
Indication: Treatment of focal segmental glomerulosclerosis
Sponsor: Genzyme Europe B.V.
Gooimeer 10, NL-1411 DD Naarden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/08/2011 Orphan designation EMA/OD/146/10 (2011)5807 of 05/08/2011
31/07/2015 Removal of orphan designation from Community Register